author-photo

Guillermo Garcia-Manero

University of Texas at Austin
University of Texas Health Science Center at Houston

78

Papers

1594

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Iron Chelation in Transfusion-Dependent Patients With Low Myelodysplastic Syndromes: A Randomized Trial.

2020 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (28)
Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (1)
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry

2020
Show All
- Source
- Cite
- Save
Citations (0)
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000

2018 Cancer
Show All
- Source
- Cite
- Save
Citations (16)
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase

2018 Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

2018 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (207)
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression

2018 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (45)
Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (25)
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (107)
Phase 2 study of low‐dose clofarabine plus cytarabine for patients with higher‐risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents

2017 Cancer
Show All
- Source
- Cite
- Save
Citations (18)